MarketCap
Facebook
X
TelegramGeschäftsbericht 2025
hinzugefügt 03.01.2026
Cognyte Software Ltd. Betriebsaufwand 2011-2026 | CGNT
Betriebsaufwand Jährlich Cognyte Software Ltd.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 293 M | - | - | - | 38.3 M | 35.2 M | 31 M | 11.9 M | 12.8 M | 15.2 M | 14.3 M |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 293 M | 11.9 M | 56.4 M |
Betriebsaufwand anderer Aktien in der Medizinische Geräte
| Name | Betriebsaufwand | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Acutus Medical
AFIB
|
8.59 M | - | -26.83 % | $ 2.62 M |  USA |
 |
Allied Healthcare Products
AHPI
|
7.81 M | - | 3.58 % | $ 2.21 M | USA |
 |
AxoGen
AXGN
|
121 M | $ 30.83 | -0.32 % | $ 1.36 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
263 M | - | - | $ 3.31 B | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
79 M | - | - | $ 1.77 B | USA |
 |
Conformis
CFMS
|
69.5 M | - | - | $ 16.4 M | USA |
 |
Abiomed
ABMD
|
456 M | - | - | $ 17.2 B | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
11.2 M | - | -5.86 % | $ 30.6 M | USA |
 |
CONMED Corporation
CNMD
|
533 M | $ 41.91 | 4.76 % | $ 1.29 B | USA |
 |
Apollo Endosurgery
APEN
|
73.8 M | - | - | $ 475 M | USA |
 |
Apyx Medical Corporation
APYX
|
53.7 M | $ 3.87 | -0.26 % | $ 134 M | USA |
 |
Alphatec Holdings
ATEC
|
560 M | $ 15.99 | -2.8 % | $ 2.29 B | USA |
 |
Cutera
CUTR
|
198 M | - | -10.19 % | $ 1.99 M | USA |
 |
Bio-Rad Laboratories
BIO
|
1.03 B | $ 317.35 | -1.51 % | $ 8.95 B | USA |
 |
EDAP TMS S.A.
EDAP
|
20.8 M | $ 4.0 | -2.2 % | $ 149 M |  France |
 |
Dynatronics Corporation
DYNT
|
18.1 M | - | 14.99 % | $ 929 K | USA |
 |
Bruker Corporation
BRKR
|
1.4 B | $ 49.4 | -2.91 % | $ 7.36 K | USA |
 |
BioSig Technologies
BSGM
|
12.9 M | - | 37.08 % | $ 85.7 M | USA |
 |
Boston Scientific Corporation
BSX
|
8.89 B | $ 93.46 | -0.68 % | $ 138 B | USA |
 |
Abbott Laboratories
ABT
|
14.1 B | $ 124.69 | 0.35 % | $ 217 B | USA |
 |
CryoLife, Inc.
CRY
|
165 M | - | -4.14 % | $ 702 M | USA |
 |
Soliton, Inc.
SOLY
|
14.4 M | - | -1.42 % | $ 435 M | USA |
 |
Cardiovascular Systems
CSII
|
209 M | - | 0.15 % | $ 844 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
9.14 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
39.1 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
63.1 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
36.4 M | - | - | $ 111 M |  Canada |
 |
Integra LifeSciences Holdings Corporation
IART
|
794 M | $ 12.46 | 0.97 % | $ 960 M | USA |
 |
Zynex
ZYXI
|
69.9 M | - | - | $ 21.1 M | USA |
 |
Invacare Corporation
IVC
|
260 M | - | - | $ 24.7 M | USA |
 |
IRIDEX Corporation
IRIX
|
31.8 M | $ 1.32 | -4.35 % | $ 21.3 M | USA |
 |
Intersect ENT, Inc.
XENT
|
118 M | - | - | $ 955 M | USA |
 |
Eargo
EAR
|
126 M | - | - | $ 10.2 M | USA |
 |
Electromed
ELMD
|
40.3 M | $ 28.27 | 1.0 % | $ 239 M | USA |
 |
Pulmonx Corporation
LUNG
|
120 M | $ 2.0 | 2.56 % | $ 78.2 M | USA |
 |
InMode Ltd.
INMD
|
136 M | $ 14.05 | 0.14 % | $ 1.11 B | Israel |
 |
Second Sight Medical Products
EYES
|
24.7 M | - | -0.97 % | $ 54.4 M | USA |
 |
Align Technology
ALGN
|
2.19 B | $ 169.61 | -0.35 % | $ 12.7 B | USA |
 |
Accuray Incorporated
ARAY
|
139 M | $ 0.84 | -2.44 % | $ 86.3 M | USA |
 |
IRadimed Corporation
IRMD
|
34.4 M | $ 101.77 | 2.54 % | $ 1.29 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
184 M | $ 18.52 | -0.94 % | $ 427 M | USA |
 |
Avinger
AVGR
|
18.6 M | - | -20.74 % | $ 369 K | USA |
 |
ClearPoint Neuro
CLPT
|
15.3 M | $ 15.46 | 6.81 % | $ 418 M | USA |
 |
FONAR Corporation
FONR
|
28.7 M | $ 18.61 | 0.08 % | $ 122 M | USA |
 |
GBS
GBS
|
12.7 M | - | -0.57 % | $ 7.12 M | USA |
 |
Myomo
MYO
|
20.9 M | $ 0.92 | -2.58 % | $ 6.49 M | USA |
 |
Orthofix Medical
OFIX
|
344 M | $ 14.38 | -2.94 % | $ 548 M |  Curacao |